Your browser doesn't support javascript.
loading
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Keller, Christian W; Ruck, Tobias; McHugh, Donal; Pfeuffer, Steffen; Gross, Catharina C; Korsukewitz, Catharina; Melzer, Nico; Klotz, Luisa; Meuth, Sven G; Münz, Christian; Nimmerjahn, Falk; Wiendl, Heinz; Lünemann, Jan D.
Affiliation
  • Keller CW; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Ruck T; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • McHugh D; Laboratory of Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Pfeuffer S; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Gross CC; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Korsukewitz C; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Melzer N; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Klotz L; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Meuth SG; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Münz C; Laboratory of Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Nimmerjahn F; Department of Biology, Institute of Genetics, University of Erlangen-Nürnberg, Erlangen, Germany.
  • Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Lünemann JD; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Ann Clin Transl Neurol ; 6(12): 2586-2594, 2019 12.
Article in En | MEDLINE | ID: mdl-31682087
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Outcome Assessment, Health Care / Receptors, IgG / Multiple Sclerosis, Relapsing-Remitting / Alemtuzumab / Immunologic Factors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Clin Transl Neurol Year: 2019 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Outcome Assessment, Health Care / Receptors, IgG / Multiple Sclerosis, Relapsing-Remitting / Alemtuzumab / Immunologic Factors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Clin Transl Neurol Year: 2019 Type: Article Affiliation country: Germany